JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bergstrom, D. A.
Right arrow Articles by Kellar, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bergstrom, D. A.
Right arrow Articles by Kellar, K. J.

Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment

DA Bergstrom and KJ Kellar

The effects of chronic administration of the tricyclic antidepressant agent desmethylimipramine (DMI) on brain adrenergic and serotonergic receptor binding processes were studied. We examined the kinetic properties of alpha adrenergic, beta adrenergic and serotonergic receptor binding sites in cortical and subcortical brain regions of rats treated chronically for various time periods with DMI(6 mg/kg i.p. daily). After 1 week of daily injections, beta receptor binding density in the cortex was significantly decreased. The reduced density of the cortical beta receptors was evident throughout a 12-week administration period. It was not until after 6 weeks of DMI administration that a significant reduction in the subcortical beta receptors was evident. Compared to saline-injected controls, chronic DMI administration lowered [3H]dihydroalprenolol binding in the hippocampus but not in the striatum. After 12 weeks of DMI we detected no differences in alpha adrenergic binding characteristics in the cortex or subcortical forebrain using [3H]dihydroergocryptine as the binding ligand. There was no consistent alteration in the cortical serotonin receptor densities throughout the 12 weeks of DMI administration, and DMI had no effect on the serotonergic binding characteristics in the subcortical forebrain region. We conclude that chronic DMI administration selectively decreases the density of beta adrenergic receptors in rat brain.

Volume 209, Issue 2, pp. 256-261, 05/01/1979
Copyright © 1979 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
A. Delini-Stula and E. Mogilnicka
Rapid changes in functional responsiveness of the 5-HT system after single-dose and multiple-dose treatment with antidepressants: effects of maprotiline and oxaprotiline and its enantiomers
J Psychopharmacol, January 1, 1989; 3(1): 7 - 13.
[Abstract] [PDF]


Home page
ScienceHome page
C. Stockmeier, A. Martino, and K. Kellar
A strong influence of serotonin axons on beta-adrenergic receptors in rat brain
Science, October 18, 1985; 230(4723): 323 - 325.
[Abstract] [PDF]


Home page
ScienceHome page
L. Chiodo and S. Antelman
Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment
Science, November 14, 1980; 210(4471): 799 - 801.
[Abstract] [PDF]


Home page
ScienceHome page
S. Peroutka and S. Snyder
Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding
Science, October 3, 1980; 210(4465): 88 - 90.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics.